ARCHIVES

FDA Approves Gleevec For First Line Rx Of CML

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Requests $5.69 Billion To Seize Opportunities In FY03.

January 11, 2002

NCI May Ask Grantees To Assume Additional Services, Broder Says

November 11, 1994

Karkin, Hatfield Vow to Amend Health Reform To Include Trust Fund For Medical Research

June 4, 1993

DCPC Board Okays Start of Low Fat High Risk Breast Cancer Study, Delays Stage 2 Trial

February 1, 1985

Cancer Control Survey Determines Manpower Needs for Quality Care

July 9, 1976

Also NIH institute directors earn higher salaries than Vice President Cheney; House subcommittee investigating pay of top NIH officials.

February 6, 2004